Search

Displaying results 4481 - 4490 of 7602 in total
  1. Drug

    AC-430

    go.drugbank.com/drugs/DB12535
    Investigational

    AC430 has been investigated for the treatment of Rheumatoid Arthritis.

  2. Drug

    Bi104

    go.drugbank.com/drugs/DB18743
    Experimental

    Bi104 is being investigated for the treatment of Angelman syndrome.

  3. Drug

    Vamifeport

    go.drugbank.com/drugs/DB17692
    Investigational

    Vamifeport is being investigated for the treatment of beta-thalassemia.

  4. Drug

    PB127

    go.drugbank.com/drugs/DB06208
    Investigational

  5. Drug

    Glycylglutamine

    go.drugbank.com/drugs/DB15990
    Investigational

    Mixtures: GLAMIN SOLUTION FOR INFUSION
  6. Drug

    Cannabinor

    go.drugbank.com/drugs/DB05048
    Experimental

    Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.

  7. Drug

    ETC-1001

    go.drugbank.com/drugs/DB05866
    Experimental

    ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.

  8. Drug

    ATX-101

    go.drugbank.com/drugs/DB05780
    Investigational

    ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits. … ATX-101 demonstrates a relative selectivity for fat over other tissues.

  9. Drug

    Bunamidine

    go.drugbank.com/drugs/DB11501
    ExperimentalVet approved

    Bunamidine is a veterinary anti-platyhelmintic agent used for taenia infestations.

  10. Drug

    Belotecan

    go.drugbank.com/drugs/DB12459
    Investigational

    Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer.